Cotellic 20 mg (Cobimetinib (Cobimetinib Fumarate) TABLET) 20 MG

Cobimetinib (COTELLIC 20 MG) is a tablet used in cancer treatment. This medication, manufactured by Hoffmann-La Roche Limited, is an oral therapy designed to target specific proteins involved in cancer cell growth.

Strength

20 MG

Pack Size

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cobimetinib (COTELLIC 20 MG) is primarily used in combination with other cancer therapies. It is designed to target specific proteins that play a role in the growth and spread of cancer cells. This medication is often used in the treatment of advanced melanoma, a type of skin cancer. Patients should consult their healthcare provider to determine if this medication is suitable for their specific condition.

Side Effects

Common effects of Cobimetinib (COTELLIC 20 MG) may include fatigue, nausea, and diarrhea. Some users may also experience skin reactions such as rash or dry skin. These effects can vary in intensity and duration, and it is important to discuss any concerns with a healthcare professional.

Precautions & Warnings

Cobimetinib (COTELLIC 20 MG) should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Avoid Interactions

Cobimetinib (COTELLIC 20 MG) may interact with other medications, including those that affect the liver's ability to metabolize drugs. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

References

Frequently Asked Questions

Cobimetinib (COTELLIC 20 MG) is used in combination with other therapies for the treatment of advanced melanoma, a type of skin cancer.

Cobimetinib (COTELLIC 20 MG) is taken orally, typically once daily. Follow the specific instructions provided by your healthcare professional.

Common side effects may include fatigue, nausea, diarrhea, and skin reactions such as rash or dry skin.

It is generally advised to avoid alcohol while taking Cobimetinib (COTELLIC 20 MG) as it may interact with the medication.

If you miss a dose, consult your healthcare provider for guidance on when to take the next dose.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.